Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy
- PMID: 17112987
- DOI: 10.1016/j.jacc.2006.07.049
Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy
Abstract
Objectives: We studied the prognostic implications of midwall fibrosis in dilated cardiomyopathy (DCM) in a prospective longitudinal study.
Background: Risk stratification of patients with nonischemic DCM in the era of device implantation is problematic. Approximately 30% of patients with DCM have midwall fibrosis as detected by late gadolinium-enhancement (LGE) cardiovascular magnetic resonance (CMR), which may increase susceptibility to arrhythmia and progression of heart failure.
Methods: Consecutive DCM patients (n = 101) with the presence or absence of midwall fibrosis were followed up prospectively for 658 +/- 355 days for events.
Results: Midwall fibrosis was present in 35% of patients and was associated with a higher rate of the predefined primary combined end point of all-cause death and hospitalization for a cardiovascular event (hazard ratio 3.4, p = 0.01). Multivariate analysis showed midwall fibrosis as the sole significant predictor of death or hospitalization. However, there was no significant difference in all-cause mortality between the 2 groups. Midwall fibrosis also predicted secondary outcome measures of sudden cardiac death (SCD) or ventricular tachycardia (VT) (hazard ratio 5.2, p = 0.03). Midwall fibrosis remained predictive of SCD/VT after correction for baseline differences in left ventricular ejection fraction between the 2 groups.
Conclusions: In DCM, midwall fibrosis determined by CMR is a predictor of the combined end point of all-cause mortality and cardiovascular hospitalization, which is independent of ventricular remodeling. In addition, midwall fibrosis by CMR predicts SCD/VT. This suggests a potential role for CMR in the risk stratification of patients with DCM, which may have value in determining the need for device therapy.
Comment in
-
The expanding prognostic role of late gadolinium enhanced cardiac magnetic resonance.J Am Coll Cardiol. 2006 Nov 21;48(10):1986-7. doi: 10.1016/j.jacc.2006.08.018. Epub 2006 Oct 31. J Am Coll Cardiol. 2006. PMID: 17112988 Review. No abstract available.
Similar articles
-
Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.JAMA. 2013 Mar 6;309(9):896-908. doi: 10.1001/jama.2013.1363. JAMA. 2013. PMID: 23462786
-
Prediction of ventricular arrhythmias using cardiovascular magnetic resonance.Eur Heart J Cardiovasc Imaging. 2013 Jun;14(6):518-25. doi: 10.1093/ehjci/jes302. Epub 2013 Jan 16. Eur Heart J Cardiovasc Imaging. 2013. PMID: 23324829 Review.
-
Ventricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy.J Am Coll Cardiol. 2007 Jul 17;50(3):225-31. doi: 10.1016/j.jacc.2007.02.071. Epub 2007 Jun 29. J Am Coll Cardiol. 2007. PMID: 17631214
-
[The natural history of dilated cardiomyopathy: a review of the Heart Muscle Disease Registry of Trieste].Ital Heart J Suppl. 2004 Apr;5(4):253-66. Ital Heart J Suppl. 2004. PMID: 15346692 Review. Italian.
-
Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.Circulation. 2003 Jul 8;108(1):54-9. doi: 10.1161/01.CIR.0000078641.19365.4C. Epub 2003 Jun 23. Circulation. 2003. PMID: 12821550 Clinical Trial.
Cited by
-
Emerging Concepts of Mechanisms Controlling Cardiac Tension: Focus on Familial Dilated Cardiomyopathy (DCM) and Sarcomere-Directed Therapies.Biomedicines. 2024 May 2;12(5):999. doi: 10.3390/biomedicines12050999. Biomedicines. 2024. PMID: 38790961 Free PMC article. Review.
-
Cardiovascular Magnetic Resonance Imaging in Myocardial Disease.Cureus. 2024 Apr 21;16(4):e58688. doi: 10.7759/cureus.58688. eCollection 2024 Apr. Cureus. 2024. PMID: 38774162 Free PMC article. Review.
-
3-Tesla cardiac magnetic resonance imaging in primary dilated cardiomyopathy.Afr J Thorac Crit Care Med. 2024 Apr 4;30(1):e844. doi: 10.7196/AJTCCM.2024.v30i1.844. eCollection 2024. Afr J Thorac Crit Care Med. 2024. PMID: 38756390 Free PMC article.
-
Multiparametric cardiac magnetic resonance in patients with thalassemia intermedia: new insights from the E-MIOT network.Radiol Med. 2024 Jun;129(6):879-889. doi: 10.1007/s11547-024-01821-y. Epub 2024 Apr 29. Radiol Med. 2024. PMID: 38683500
-
Current Insights and Novel Cardiovascular Magnetic Resonance-Based Techniques in the Prognosis of Non-Ischemic Dilated Cardiomyopathy.J Clin Med. 2024 Feb 9;13(4):1017. doi: 10.3390/jcm13041017. J Clin Med. 2024. PMID: 38398330 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical